Literature DB >> 24092259

Venous thromboembolism prophylaxis in hematopoietic stem cell transplantation patients: an international web-based survey of healthcare providers.

Amer M Zeidan1, Jessica Wellman, Patrick M Forde, Javier Bolaños-Meade, Michael B Streiff.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24092259      PMCID： PMC4086620          DOI： 10.1007/s11239-013-1002-0

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN： 0929-5305            Impact factor:   2.300


× No keyword cloud information.
  5 in total

1.  Hemostatic complications in bone marrow transplantation: a retrospective analysis of 447 patients.

Authors:  Rudolf Pihusch; Christoph Salat; Edwin Schmidt; Peter Göhring; Markus Pihusch; Erhard Hiller; Ernst Holler; Hans-Jochem Kolb
Journal:  Transplantation       Date:  2002-11-15       Impact factor: 4.939

Review 2.  Thrombotic complications after haematopoietic stem cell transplantation: early and late effects.

Authors:  Dimitrios A Tsakiris; André Tichelli
Journal:  Best Pract Res Clin Haematol       Date:  2009-03       Impact factor: 3.020

3.  Incidence of symptomatic venous thromboembolism following hematopoietic stem cell transplantation.

Authors:  A Gonsalves; M Carrier; P S Wells; S A McDiarmid; L B Huebsch; D S Allan
Journal:  J Thromb Haemost       Date:  2008-07-08       Impact factor: 5.824

Review 4.  Venous thromboembolism in the hematologic malignancies.

Authors:  Anna Falanga; Marina Marchetti
Journal:  J Clin Oncol       Date:  2009-09-14       Impact factor: 44.544

5.  The incidence of and risk factors for venous thromboembolism (VTE) and bleeding among 1514 patients undergoing hematopoietic stem cell transplantation: implications for VTE prevention.

Authors:  David E Gerber; Jodi B Segal; M Yair Levy; Joyce Kane; Richard J Jones; Michael B Streiff
Journal:  Blood       Date:  2008-05-14       Impact factor: 22.113
  5 in total
  1 in total

1.  Late-occurring venous thromboembolism in allogeneic blood or marrow transplant survivors: a BMTSS-HiGHS2 risk model.

Authors:  Radhika Gangaraju; Yanjun Chen; Lindsey Hageman; Jessica Wu; Liton Francisco; Michelle Kung; Daniel J Weisdorf; Stephen J Forman; Mukta Arora; Saro H Armenian; Smita Bhatia
Journal:  Blood Adv       Date:  2021-10-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.